Clinical Trial News Archive - July 2023
July 3, 2023
July 4, 2023
July 5, 2023
- Zenocutuzumab (Zeno) Granted Second Breakthrough Therapy Designation by the U.S. Food & Drug Administration
- Janssen Announces Positive Topline Results for JNJ-2113 - a Novel, First and Only Oral IL-23 Receptor Antagonist Peptide in Development for Moderate-to-Severe Plaque Psoriasis
- Preclinical Data Demonstrates Efficacy of CAR-CIK Cells in Acute Myeloid Leukemia
- Investigational Three-Month TB Regimen Is Safe But Ineffective, NIH Study Finds
July 7, 2023
- Researchers Find Weaker Immune Response to Viral Infections in Children with Mitochondrial Disorders
- FDA grants traditional approval for Leqembi for the treatment of Alzheimer's disease
July 10, 2023
- New Data Shows Significant Improvement of Mild-to-Moderate Atopic Dermatitis
- Phase 1 Study Indicates Allogeneic Cytokine-Induced Memory-Like Natural Killer Cells Plus N-803 May Induce Tumor Regression in Advanced Head-and-Neck Cancer Patients
July 11, 2023
- Achieve Life Sciences Announces Publication of Cytisinicline Phase 3 ORCA-2 Smoking Cessation Trial in Journal of the American Medical Association (JAMA)
- Cingulate Announces Positive Top-Line Results from Phase 3 Adult Efficacy and Safety Trial of CTx-1301 (dexmethylphenidate) for ADHD
- The AHEAD Study Is Testing Lecanemab At The Stage Of Preclinical Alzheimer's Disease
- Xspray Pharma Receives Request for Additional Information Concerning Dasynoc from FDA
- Journey Medical Corporation Announces Positive Topline Results from its Two Phase 3 Clinical Trials (MVOR-1 and MVOR-2) Evaluating DFD-29 for the Treatment of Papulopustular Rosacea in Adults
July 12, 2023
July 13, 2023
- Low-Dose Atropine Eyedrops No Better Than Placebo for Slowing Myopia Progression
- Gender Disparities in Lyme Disease: Women Face Higher Risk of Severe and Prolonged Illness
July 14, 2023
July 17, 2023
- Results from Lilly's Landmark Phase 3 Trial of Donanemab Presented at Alzheimer's Association Conference and Published in JAMA
- Laboratory Study Shows Oral Antacid Drug Performs Differently When Mixed with Various Food Vehicles
- BioLineRx Announces Initiation of Randomized Phase 2 Clinical Trial in First Line Metastatic Pancreatic Cancer Based on Preliminary Data from Single-Arm Pilot Phase; Combination Trial Includes Investigational Candidate Motixafortide
July 19, 2023
- Interim Positive Results from Pre-Clinical Studies in Irritable Bowel Syndrome Program
- Women Treated for Breast Cancer May Age Faster Than Cancer-Free Women
- New Atlas of Human Kidney Cells to Help Unlock Kidney Disease Research
- Pfizer Announces New England Journal of Medicine Publication on Group B Streptococcus (GBS) Maternal Vaccine Candidate
- FDA Grants Fast Track Designation for Ambrx’s ARX517 for the Treatment of Metastatic Castration-Resistant Prostate Cancer
July 20, 2023
- Omega-3 Fatty Acids Appear Promising for Maintaining Lung Health
- Promontory Therapeutics Expands Phase 2 Trial of PT-112 in Metastatic Castrate-Resistant Prostate Cancer to France
July 21, 2023
- Gilead To Discontinue Phase 3 ENHANCE Study of Magrolimab Plus Azacitidine in Higher-Risk MDS
- NIH Awards Will Fund Post-Treatment Lyme Disease Syndrome Research
- First Atopic Dermatitis Patient Dosed with LNK01004 in Phase Ib Clinical Study
July 24, 2023
- Daily Statin Reduces Heart Disease Risk Among Adults Living With HIV
- Positive Topline Results from the Pivotal AGAVE-201 Trial of Axatilimab in Chronic Graft-Versus-Host Disease
- Strawberry Consumption May Improve Cognitive Function in Older Adults, New Study Says
July 25, 2023
- Cervical Pessary No More Effective Than Usual Care in Preventing Preterm Birth Risk
- Successful New Nymozarfex Long-Term Prostate Cancer Treatment Clinical Trial Results
July 26, 2023
- CoImmune Announces Publication of Preclinical Results with SEAKER Cells in Solid Tumor Melanomas
- Merck and Moderna Initiate Phase 3 Study Evaluating V940 (mRNA-4157) in Combination with Keytruda (pembrolizumab) for Adjuvant Treatment of Patients with Resected High-Risk(Stage IIB-IV) Melanoma
- The New England Journal of Medicine Publishes Data from Phase 2 Study of First Oral Orexin Receptor 2 Agonist TAK-994 in Patients with Narcolepsy Type 1
- NIH-Funded Study Explains Link to Increased Cardiovascular Risks for People with Obstructive Sleep Apnea
July 27, 2023
July 28, 2023
July 31, 2023
- NIH Launches Long COVID Clinical Trials Through RECOVER Initiative, Opening Enrollment
- FDA Grants Fast Track designation to IVS-3001, a CAR-T Cell Therapy in the Treatment of Renal Cell Carcinoma
- Tirzepatide Demonstrated Significant and Superior Weight Loss Compared to Placebo in Two Pivotal Studies
- Study Confirms Effectiveness of Trilaciclib for Treatment of Patients with Extensive-Stage Small Cell Lung Cancer
Clinical trial results archive
- 2024
- January, February, March, April, May, June, July, August, September, October, November, December
- 2023
- January, February, March, April, May, June, July, August, September, October, November, December
- 2022
- January, February, March, April, May, June, July, August, September, October, November, December
- 2021
- January, February, March, April, May, June, July, August, September, October, November, December
- 2020
- January, February, March, April, May, June, July, August, September, October, November, December
- 2019
- January, February, March, April, May, June, July, August, September, October, November, December
- 2018
- January, February, March, April, May, June, July, August, September, October, November, December
- 2017
- May, June, July, August, September, October, November, December
- 2016
- October
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.